ReleaseWire Connect

In 2014, the Chinese aluminum rolled product market grew steadily with the aluminum sheet / strip output of 10 million tons and the aluminum foil output of 3.08 million tons, representing the respective increase of 8.7% and 10.0%. By 2017, China's aluminum sheet / strip output and aluminum foil output are expected to reach 12.61 million tons and 3.91 million tons respectively.

The shipbuilding industry is involved in the construction and modification of ships and these operations are carried out in specialized facilities called shipyards. The industry builds ships for commercial as well as military purposes. The shipbuilding market is segmented on the basis of ship type: Bulkers, Tankers, Containers, LPG & LNG and other special vessels. Shipbuilding industry is mostly dominated by Asian players, such as South Korea, China and Japan. Traditional large shipbuilders in the region, such as Korea, China, and Japan, as well as Southeast Asia, are enhancing their offshore capabilities and providing a single marine solution for both shipbuilding and offshore.

Building metal parts is the only way 3D printing can become productive. Plastic 3D printing has its place in prototyping and education, but 3D printing in metal will allow the technology to be used to manufacture final production parts in a wide variety of industries. Metals are the fastest-growing segment of 3D printing, with printer sales growing at 48% and material sales growing at 32%.

The market for infant formula is one of the major and fastest growing segments of the overall baby food industry. Infant formula is manufactured food, designed and marketed for feeding to babies and infants less than 12 months of age. All over the world parents are becoming more concerned about the nutritional benefit of pediatric foods and breast-milk supplements.

DelveInsight's, HIV-2 Protease (HIV-2 PR) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the HIV-2 Protease (HIV-2 PR) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The HIV-2 Protease (HIV-2 PR) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, T Cell Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the T Cell Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The T Cell Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, 11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the 11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, Focal Adhesion Kinase (FAK) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Focal Adhesion Kinase (FAK) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Focal Adhesion Kinase (FAK) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, Raf/MEK/ERK Signaling Cascade Inhibitirs- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Raf/MEK/ERK Signaling Cascade Inhibitirs. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Raf/MEK/ERK Signaling Cascade Inhibitirs Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, Angiotensin II Receptor Type 2 (AT2 Receptor) Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Angiotensin II Receptor Type 2 (AT2 Receptor) Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Angiotensin II Receptor Type 2 (AT2 Receptor) Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.